Please assess the completion status of the following clinical trial:

Trial Title: Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females ≥ 18 years of old.~2. Clinical diagnosis of type 1 diabetes for at least one year.~3. HbA1c ≤ 9.5%.~4. Patients using multiple daily injections with basal-bolus insulin regimen and insulin analogs (pre-meal: Aspart, Lispro, Guilisine or Fiasp; basal: Detemir, Glargine U100 \& U300, Degludec U100).~5. Written informed consent given.~Exclusion Criteria:~1. Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy (especially diagnosed gastroparesis) or severe proliferative retinopathy as judged by the investigator.~2. Recent (\< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.~3. Anemia (Hb \< 100g/L).~4. Ongoing pregnancy or breastfeeding.~5. Severe hypoglycemic episode within two weeks of screening.~6. Other serious medical illness likely to interfere with study participation or with the ability to complete the exercise periods by the judgment of the investigator (e.g. orthopedic limitation).~7. Ongoing treatment with CSII (Continuous Subcutaneous Insulin Infusion) insulin pump therapy.~8. Participation to a clinical trial in the last 3 months prior to inclusion in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Aspart - 60-minutes postprandial exercise (Type: ACTIVE_COMPARATOR): None
- Aspart - 120-minutes postprandial exercise (Type: ACTIVE_COMPARATOR): None
- FiAsp - 60-minutes postprandial exercise (Type: ACTIVE_COMPARATOR): None
- FiAsp - 120-minutes postprandial exercise (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).